Sanda Win, MBBS, PhD

Dr. Win’s major areas of research interest are signal transduction in drug-induced hepatotoxicity, regulation of mitochondrial bioenergetic signaling in hepatotoxicity, metabolic dysfunction-associated steatotic liver disease (MASLD), and alcoholic hepatitis, oxidative stress, and identification of therapeutic targets to prevent drug-induced hepatotoxicity and metabolic dysfunction-associated steatotic liver disease (MASLD) (previous term: nonalcoholic fatty liver disease, NAFLD). Her current research includes cellular mechanisms of hepatotoxicity.

Dr. Win earned her medical degree from University of Yangon Institute of Medicine. She then went on to perform her Medicine and Surgery Internship and Residency at University of Yangon General Hospital, followed by her PhD in Immunology & Molecular Biology from Okayama University Graduate School of Medicine and Dentistry.

• American Association for the Study of Liver Disease: Presidential Poster of Distinction, 2020
• American Association for the Study of Liver Disease: Presidential Poster of Distinction, 2020
• Baxter Foundation: Donald E. and Delia B. Baxter Foundation Faculty Fellowship Award, 2018
• NIH: Research Center for Liver Diseases, Keck School of Medicine of USC Research Pilot Award, 2016
• American Association for the Study of Liver Disease: Presidential Poster of Distinction, 2014
• Sagawa Scholarship Foundation, Japan: Award for Doctoral Program, 2001

• Awards & Recognitions
• USC scientists discover a novel therapeutic target to treat fatty liver disease (October 29, 2021)
• The Baxter Foundation awards grants to USC researchers Michael Bonaguidi and Sanda Win (August 27, 2018)

• Kaplowitz, Neil
• Dara, Lily
• Cohen, Pinchas
• Papadopoulos, Vassilios
• Fernandez-Checa Torres, Jose
• Than, Tin